Integrin Inhibitor | Target Integrin | Clinical trial |
---|
Intetumumab (CNTO 95) | αV | Phase II [129] |
Abituzimab (DI17E6, EMD 525797) | αV | Phase I/II [153] |
MK-0429 | αVß3 | – |
Cilengitide (EMD 121974) | αVß3 αVß5 | Phase II/III [135, 137] |
D-pinitol | αVß3 | – |
GLPG0187 | αVß3 | Phase I [144] |
Volociximab (M200) | α5ß1 | Phase II [148] |
PF-04605412 | α5ß1 | Phase I [149] |